Post on 30-May-2018
8/14/2019 Kredent_Indian Healthcare Sector
1/30
www.kredent.com research@kredent.com
1
Equity Research
Indian Healthcare Industry:Poised For Growth
11th
January, 2010
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
2/30
www.kredent.com research@kredent.com
2
Equity Research
Table of Contents
Process Flow Chart 03
Business Model 04
Parameter Evaluation Chart.. 06
Final Recommendations. 10
Overv iew of Indian Healthcare Sector
Introduction.. 11
Opportunities... 11
The Niche Sector: Wellness Sector. 15
Swot Analysis...19
Peer Comparison... .20
Zydus Wellness..... .21
Kovai Medical centre And Hospital Ltd....25
Disclaimer.29
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
3/30
www.kredent.com research@kredent.com
3
Equity Research
Process Flow
We choose all companies that were listed on BSE and werethere in the healthcare industry
A total of 17 listed companies were selected in this industry
In the next step, the various segments of this industry was
identified The companies with maximum presence in this segments and
those with niche presence were chosen
We short listed 12 companies on the basis of their businessmodels
In this stage we conducted a financial analysis of the above 12companies and scored them according to their performance in the
various ratios We also had a look at the market cap of the complete 17 companies
Stage 1
Stage 2
Stage 3
In the financial analysis we chose 7 out of 12 companies while inthe market cap category we chose 9 out of 17 companies
Then we chose those companies which was found common in the
above two categories Finally, after an extensive study of these companies we short listed
four companies
Stage 4
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
4/30
www.kredent.com research@kredent.com
4
Equity Research
Stage 1:
Study on business model and segmential presence
IT
WellnessCenters
SpecialtyHospitals
Biotech
DiagnosticCenters
MultispecialityHospitals
BusinessModel
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
5/30
www.kredent.com research@kredent.com
5
Equity Research
Stage 2:
The presence of the companies in the various segments of the industry is shown below:
Selection Grounds
CompaniesMultispecialty
hospitals Diagnostic Biotech ITSpecialtyhospitals Wellness
Apollo Hospitals EnterpriseLtd. Y Y N N N NChennai MeenakshiMultispeciality Hospital Ltd Y Y N N N NDolphin Medical ServicesLtd. N Y Y Y N NDr Agarwal's Eye Hospital
Ltd. N N N N Y NFortis Healthcare Ltd. Y N N N N NIndraprastha MedicalCorpn. Ltd. Y N N N N N
Invicta Meditek Ltd. N N N N N NKovai Medical Center &Hospital Ltd Y N N N N NLotus Eye Care HospitalLtd N N N N Y N
Malar Hospitals Ltd. N N N N Y N
NG Industries Ltd. Y Y N N N NNoida Medicare CentreLtd. Y Y N N N NSecunderabad HealthcareLtd. N N N N N NSiemens HealthcareDiagnostics Ltd. N Y N Y N N
Transgene Biotek Ltd. N N N N N N
Zydus Wellness N N N N N Y
Marico N N N N Y Y
Source: Kredent Group
On the basis of business model study, 12 companies were short listed and were put through thefinancial analysis scanner.
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
6/30
www.kredent.com research@kredent.com
6
Equity Research
Stage 3:
The various ratios taken for evaluation were considered to get an estimate of the overall performance ofthe companys health
RATIOS
ProfitabilityRatios
Pat margin
EBIT Margin
ROE ROCE Pat Growth
EPS Growth
Solvency ratios
InterestCoverage
Debt-equity
LiquidityRatios
CurrentRatio
OCF Ratio
Quick Ratio
ValuationRatios
PEG Ratio P/B
PE Ratio
Mkt.cap/Sales
Other Ratios
SalesGrowth
Retentionratio
Sales/TotalAssets
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
7/30
www.kredent.com research@kredent.com
7
Equity Research
The above 17 companies were analyzed on the basis of financial ratios and were marked according totheir performance in these various fields (ratios)
133
7
123
1714
813
129
13
0 5 10 15 20
Apollo Hospitals Enterpr ise Ltd.
Chennai Meenakshi Multispeciality
Hospital Ltd
Dolphin Medical Services Ltd.
Dr Agarwal'S Eye Hospital Ltd.
Fortis Healthcare Ltd.
Indraprastha Medical Corpn. Ltd.
Kovai Medical Center & Hospital Ltd
Lotus Eye Care Hospital Ltd
Marico Ltd.
Noida Medicare Centre Ltd.
Siemens Healthcare Diagnostics Ltd.
Zydus Wellness Ltd
Note: Higher score means good performance while lower score means poor performanceSource: Kredent Group
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
8/30
www.kredent.com research@kredent.com
8
Equity Research
The market cap of the companies was also considered in this stage. We selected a range in the market
cap for which the companies were to be chosen. The market cap of the companies is given below:
The companies who had their market cap in the range of 1100 crores to15 croreswere short listed
Name of the CompanyMarket cap(in cr.)
Marico Ltd. 6,314.97Apollo Hospitals Enterprise Ltd. 3,456.86
Fortis Healthcare Ltd. 2,669.10
Zydus Wellness Ltd 1,070.58
Indraprastha Medical Corporation Ltd. 372.19
Siemens Healthcare Diagnostics Ltd. 163.84
Kovai Medical Center & Hospital Ltd 110.41
Lotus Eye Care Hospital Ltd 73.1
Transgene Biotek Ltd. 71.5Malar Hospitals Ltd. 52.81
Dr Agarwal's Eye Hospital Ltd. 22.73
Noida Medicare Centre Ltd. 15.23
Dolphin Medical Services Ltd. 7.46
Chennai Meenakshi Multispecialty Hospital Ltd 6.72
Secunderabad Healthcare Ltd. 6.35
Socrus Bio Sciences Ltd 4.7
Invicta Meditek Ltd. 2.68Source: Ace Equity
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
9/30
www.kredent.com research@kredent.com
9
Equity Research
In the final step of stage 3 we selected the companys which performed well in the financial analysis and
also fell in the selected market cap range. The selection is represented below:Financial Analysis Market cap
Selected Companies
Source: Kredent Analysis
Zydus Wellness
Dr. Agarwals Eye
Hospital Ltd.
Noida Medicare centre
Ltd.
Kovai Medical Centre &Hospital Ltd.
Indrapastha Medical
Corpn. Ltd
Zydus Wellness Ltd
Indraprastha Medical
Corpn. Ltd.
Siemens Healthcare
Diagnostics Ltd.
Kovai Medical Center &
Hospital Ltd Lotus Eye Care Hospital
Ltd
Transgene Biotek Ltd.
Malar Hospitals Ltd.
Dr Agarwal'S EyeHospital Ltd.
Noida Medicare CentreLtd.
Apollo HospitalsEnterprise Ltd.
Dr Agarwal's EyeHospital Ltd.
Indraprastha Medical
Corporation. Ltd.
Kovai Medical Center
& Hospital Ltd
Marico Ltd.
Noida Medicare Centre
Ltd.
Zydus Wellness Ltd
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
10/30
www.kredent.com research@kredent.com
10
Equity Research
Recommendations
Finally, the above selected five companies were considered for detailed analysis. We went through thecompanys annual reports and management discussion & analysis section. We also analyzed theirsources of revenue, capex plans, individual risks, product range, etc. At the end, we came down to twocompanies, which are finally recommended.
Companies View
Zydus Wellness Ltd. Buy
Kovai Medical centre & Hospital Ltd. Buy
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
11/30
www.kredent.com research@kredent.com
11
Equity Research
Introduction
Healthcare industry is the world's largest industry with total revenues of approx US$ 2.8 Trillion (2005) It constitutes 5.2% of Indias GDP and employs 4 million people It is expected to grow at 15% per annum to US$78.6, reaching 6.1% of GDP and employing 9 million
people by 2012 The sector has registered a growth of 9.3% between 2000-2009, comparable to the sectoral growth
rate of other emerging economies such as China, Brazil and Mexico It is a US$ 35 billion industry in India, and is expected to reach over US$ 75 billion by 2012 and US$
150 billion by 2017 (CII). This would include pharmaceuticals, hospitals and diagnostics, healthinsurance and medical tourism
According to the IRDA, the Indian healthcare industry has the potential to show the same exponentiagrowth that the software industry showed in the past decade
Future of Healthcare in India
35
75
150
0
20
40
60
80
100
120
140
160
2009 2012E 2017E
US
$(in
bn)
Source: IBEF
Opportunities:
Healthcare is a non settling business, where the growth is non-cyclic in nature It has emerged as one of the most challenging as well as one of the largest service sector industries in
India The growth in the sector would be driven by healthcare facilities, both private and public sector
medical diagnostic and pathlabs and the medical insurance sector Of the sum, diagnostic and pathology services would account for $2.5 billion in 2012, more than
double its estimated current size of $1billion
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
12/30
www.kredent.com research@kredent.com
12
Equity Research
The growth in the segment is expected to be driven by consolidation in the industry and increasinginsurance penetration among the countrys population
Healthcare facilities, inclusive of public and private hospitals, the core sector, around which thehealthcare sector is centered, would continue to contribute over 70% of the total sector and touch afigure of $54.7 billion by 2012.
The various opportunities in the healthcare are segmented below
Medical Tourism:
According to the estimates of McKinsey and the CII, medical tourism in India could become a US$ 2billion industry by 2012
Medical tourism is predicted to grow at between 25-30 per cent annually ( Credit Suisse) In 2007, India treated 450,000 foreign patients ranking it second in medical tourism The advantage of this industry in India is many, like one of them being its cost effectiveness. It
provides better and cheap healthcare services than most of the other countries Treatment cost is lowest in India 20 per cent of the average cost incurred in the US, Singapore,
Thailand and South Africa
A number of private players including Max Healthcare, Apollo Hospitals, Fortis, Global Hospitals,Wockhardt, etc are already present in this sector The number of such players may get larger in times to come According to one estimate India's revenue from health care sector is expected to touch US$ 2.2 billion
from health tourists
Government has also introduced many new schemes to promote medical tourism in India like:
A new category of visa "Medical Visa" ('M'-Visa) has been introduced which can be given for aspecific purpose to foreign tourists coming into India
Reduction in custom tariffs on life saving medical equipments & clinical drugs
Depreciation rates have been increased for medical equipments under the Income Tax Laws Health insurance schemes to the poor & increased FDI limit from 2.6% to 5.1%
Health Insurance:
Health Insurance another sub-section of health care is poised to emerge as a US$ 3 bn industry in thenext three years
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
13/30
www.kredent.com research@kredent.com
13
Equity Research
Currently, it is standing at an estimated current size of $1 billion and is growing at 50 per cent Presently, there is a dismal health insurance penetration rate; only 10 per cent of the Indian population
has health insurance, which means that there is tremendous scope for growth in this area Large number of private players like Max New York life insurance and ICICI Prudential have entered
the market to cash on the booming phase
Growth in health insurance based on collected
premiums
0.711
5.75
0
1
2
3
4
5
6
7
2006 2009 2010E
U
S
$(Bn)
Source: PHD Chamber of Commerce and Industry
Increase in Lifestyle Diseases:
A shift from chronic diseases to lifestyle diseases like obesity, hypertension, diabetes and cardiacdiseases have been on rise due to lifestyle problems
Problems like career challenges and the demand for long working hours are detrimental to the adultpopulation while the middle-aged group is affected because of excess household comfort
The above reasons have a negative impact on confidence, productivity and self-esteem Indians have a higher body fat percentage and high incidence of abdominal obesity One in every five Mumbaikars is obese, and 50 per cent of urban women and 40 per cent of men are
overweight (Kaya). One can have a very good idea about the % of Indians being obese from the tablebelow:
Obese people under various age groups (%)
Children under five years 1.9
Prevalence of adult male(>= 15 years) 1.3
Prevalence of adults female (>= 15 years) 2.8
Source: WHO
Another lifestyle disease which is on rise is diabetes
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
14/30
www.kredent.com research@kredent.com
14
Equity Research
India has a dubious distinction of having the largest number of people with diabetes Every year 6 million people develop diabetes
In 1985, there were an estimated 30 million people but today, it affects more than 230 million people Recent studies have shown that for every person known to have diabetes, there are more than 2
people who have diabetes but are unaware of it In fact, many persons with Type II diabetes already show the presence of the long term complications
associated with diabetes at the time of diagnosis
Participation of PEs
The Indian healthcare industry, is attracting investment opportunities from private equity (PE) andventure capital (VC) firms
There is a huge demand supply gap in healthcare delivery business in India as there are feworganized hospital chains.
Pharma, retail, medical equipment, diagnostics services are businesses where efficiency can bebrought in by private investments
Private sector plays a significant role by contributing 4.3% of GDP and 80% share of healthcareprovision
The medical technology market was worth about $2.7 billion in 2006 and is likely to cross $10 billion by2012 with a growth rate of over 20 per cent
With the Indian software and hardware strengths, India will be a strong source for such products in
emerging markets Most MNCs are currently sourcing their products from China through OEM arrangements, joint
ventures or own manufacturing facilities Given the overall increase in prices in China, there are significant chances of India becoming a
potential alternate sourcing centre for such MNCs The different branches of healthcare where the private players are trying to make its foray are:
Diagnostic centers: The first investment of $6 million occurred in 2005, followed by another $4million in 2007. VC firm Sequoia Capital India has so far invested $10 million in Dr Lal PathLabs for a minority stake.
Hospitals: When it comes to urban areas, it is the hospitals which receive the maximum chunkof funds. In 2006, hospitals attracted 18 per cent of the total Healthcare PE investments.
Other Areas of Investment: Some of the new targets and focus areas of PE funds would bepharmacy retail chains, health and wellness centers, spas, ayurvedic and herbal skin, slimmingand beauty centers which are primarily consumer-oriented sectors. With Pantaloon Retail Indiaplanning to launch 'Health Village', and Reliance Retail launching Reliance Wellness, thissector is definitely forecasted to draw more PE funding. Corporate hospitals have shown how
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
15/30
www.kredent.com research@kredent.com
15
Equity Research
healthcare is a profitable business and thus the funds believe the other healthcare area to alsofollow the same trend
The New Wave In The Healthcare: Wellness
Wellness is being heralded as the sunrise industry of the 21st century Indian wellness services market is a US$ 2.26 billion industry Evolving lifestyle trends have revolutionized the human mindset, and a great deal of importance is now
attached to concepts such as Wellness Currently, the approach to Wellness is proactive rather than reactive While ayurveda, health foods and drinks and tonics have traditionally been integral to the Indian diet
Indians are now increasingly looking at new avenues of wellness, in line with their proactive approach To maintain and improve their Wellness, they engage in activities such as regular exercise, massage
therapies and counseling On the supply side too, industry players are increasingly moving away from curative wellbeing to
preventive and lifestyle wellbeing by providing services ranging from health-oriented hospitalspharmacies to rejuvenation based spas and yoga centers and beauty-based salons, gyms andcosmetic procedures
Increased consumer focus, along with favorable supply dynamics, has put the Wellness industry in a
sweet spot At the same time, services such as ayurveda treatment, alternative treatment centers and salons
require much lower investment and also have lower payback periods of up to three years
Wellness can be segmented into two broad categories: physical and social
Physical Wellness includes all activities related to fitness and the prevention of physical ailments.
Allopathy: Hospitals and pharmacies.
Alternative therapies: Ayurvedic medicines, products and treatments.
Social Wellness encompasses elements of mental, emotional and lifestyle wellbeing, and social Wellnessservices primarily cater to needs such as esteem, aesthetics and self-realization. They can be classifiedinto more sub-categories:
Nutrition: Dietary supplements and health and convenience foods Rejuvenation: Spas and yoga centers Exercise and fitness: Gyms and slimming centers
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
16/30
www.kredent.com research@kredent.com
16
Equity Research
Beauty: Salons and cosmetic procedures (both surgical and nonsurgical) Counselling: Professional counseling on nutrition, diet and emotional wellbeing
Holidays: Travel services
Factors affecting the wellness industry
Indian wellness industry is poised to grow at a double-digit rate over the next five years, with certain sectors, suchas spas and beauty treatments, projected to grow at more than 3540%
Moreover, given that few organized players currently exist in most Wellness segments, the opportunity for corporateand organized players is significant
Wellness sector is poised to grow because of the following growth factors:
Demand Based Factors
Enhanced awareness due toseamless international mobility
Increased disposable income andhigher discretionary spending hasled to conspicuous consumption
Need for more convenience beingdriven by changing lifestyle trends,with focus on health
People are increasingly workingtoward holistic wellness, whichincludes not only physical, but also
emotional and social
Supply-Based Factors
Multiple new channels beingexplored to offer a variety ofWellness-based products andservices
Wellness-based programs beinggiven more focus thereby,providing a platform to increasepublic awareness and also toshowcase innovative products andservices
With the entry of multiple
international companies the Indianmarket will further expand leavingthe customers with more choices
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
17/30
www.kredent.com research@kredent.com
17
Equity Research
Government Initiatives:
Healthcare is one of the 7 thrust areas under the National Common Minimum Programme (NCMP) andimprovement in health continues to be an important part in the overall strategy for socio-economicdevelopment over the planning period.
The special focus given to Health Sector in the NCMP has formed the core of the programmesformulated under both Health and Family Welfare.
The National Rural Health Mission (NRHM) is the key plank for giving effect to the mandate of theNCMP.
The Government launched the National Rural Health Mission (NRHM) in 2005 It aims to provide quality healthcare for all and increase the expenditure on healthcare from 0.9 pe
cent of GDP to 2-3 per cent of GDP by 2012 During the 2009 interim budget, the government allocated US$ 2.42 billion for NRHM The government has prioritized the health sector in the Eleventh Five Year Plan, recognizing its
significant potential and challenges The Tenth Plan period witnessed a transition in health care policies and strategies with the effecting of
an architectural correction in the healthcare delivery system at the primary and secondary level andthe steps taken to set in motion regional balance in the availability of tertiary healthcare facilities.
Wide ranging reforms and policy initiatives have been taken for improving health infrastructure andaddressing the healthcare needs of the population
Hurdles to be crossed
India has 16 per cent of the worlds population, 18 per cent of its mortality, 20 per cent of morbidity, yetthe countrys healthcare expenditure is a miniscule one per cent of global expenditure
As one of the fastest growing economies, it cannot continue to be ranked 171 out of the 175 countriessurveyed by WHO for percentage of GDP spent on public sector healthcare
According to WHO, India ranked 17th in terms of private sector health spending that is now at 4.3 per
cent of GDP The healthcare system has grown manifold over the past few years, but has not kept pace with the
rapid rise in population According to KPMG, against a world average of 4 beds per 1,000 people, India has just 0.7 There is an acute shortage of doctors, nurses, and an additional 0.7 million doctors are needed to
reach a doctor: population ratio of 1:1000 by 2025
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
18/30
www.kredent.com research@kredent.com
18
Equity Research
Another major problem is that many companies in this sector like VLCC, Himalaya, Workhardt andLifecare are not listed
Governments expenditure on healthcare is not as much as compared to other nations. As a result,private spending accounts for most of the healthcare expenditure in the country
The table below provides a comparison of India with other countries under various parameters
Particulars USA India China Japan
Number of physicians 730801 645825 1862630 270371
Hospital beds (per 10 000 population) 32 9 22 141
Per capita total expenditure on health (PPP int. $) 6719 86 216 2581
Total expenditure on health as percentage of GDP 15.3 3.6 4.6 8.1
Source: WHO
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
19/30
www.kredent.com research@kredent.com
19
Equity Research
Strength Cost-Effectiveness
Expanding Middle-class
Increased awareness among masses Good Infrastructure
One of the major drug suppliers
Weakness Lack of Quality &
Accreditation Absence of
necessaryinfrastructures
Lack of qualifiedprofessionals
High advertising &promotion costs
Threats: Competition from
other countries Presence of more
unorganized playerscompared toorganized ones
Absence of statutory& regulatorycompliances
Opportunities Shift of demand from preventive to curative
approach Demand for personalized healthcare
solutions Medical Tourism
Emerging Health Insurance Market Growth of Telemedicine
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
20/30
www.kredent.com research@kredent.com
20
Equity Research
Peer Comparison:
Particulars ZydusWellness
Dr.AgarwalsEye Hospital
NoidaMedicarecentre
Kovai MedicalCentre &Hospital
Net sales (Rs cr) 194.74 72.77 25.04 110.36
EBITDA Margins (%) 19.89 12.99 29.43 30.15
Net Profit (Rs cr) 25.41 0.19 2.12 22.21
Net profit Margins (%) 12.98 0.26 8.38 19.91
EPS 6.52 0.42 2.26 20.38
BVPS 3.53 4.18 - 37.43
CMP 273.25 51 16 102.75
P/E 41.90 121.42 7.07 5.04
P/B 3.96 54.26 - 5.03
Dividend-Yield 0.02 0.00 0.00 0.01
Market Cap/Sales 5.47 0.32 0.60 1.01
Source: Annual Report & Ace Equity
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
21/30
www.kredent.com research@kredent.com
21
Equity Research
Zydus Wellness Ltd.
BSE : 531335NSE : ZYDUSWELLBloomberg : ZYWL:INCMP : 273.25Sector : HealthcareView : Buy
Key Metrics as on 11th January, 2010
Listing BSE
Current Price (Rs) 262.40
Market Cap (Rs Cr) 1023.36
Free Float (%) 27.49
52-WEEK HIGH (Rs) 301.65
52-WEEK LOW (Rs) 52.00
BETA 0.63
P/B (x) 14.86
Current P/E (x) 40.24PEG Ratio 19.11
Dividend Yield (%) 0.02
Price Performance
Period Stock BSE
1 M -3.95 1.74
3 M 51.07 4.06
1 Year 274.86 86.33
Shareholders Pattern as on 30th Sep 2009
PROMOTER 72.51
FII 1.94
DII 16.66
PUBLIC 6.66
OTHERS 2.23
Company Background:
Zydus wellness forayed into the wellness sector bymerging consumer healthcare business of Cadilahealthcare Ltd. It provides wholesome options for healthyliving through the best of healthcare, nutrition andcosmeceuticals and has strong brand presence in allthese segments.
Investment Rationale:
It has launched Indias first skincare designed formales called MENZ, thus having a first moveradvantage
It has plans for setting up manufacturing facility forsugar-free and everyuth in sikkim
It has a strong presence in the cosmetic industrythrough brands like everyuth and menz
It is present in the health food segment with productslike nutralite, sugar-free sweetener and low calorie
health drinks (Dlite) It has a market coverage of over 80% in the sugarsubstitutes segment
It has a strong, creative and innovative marketing andbrand management strategies, forming the backboneof the consumer business
Dominant focus to accelerate the top line throughincreased manpower to rope in institutions andmodern retail formats
It has a pan India presence through a distributionnetwork of over 1 lakh outlets
Key Risks:
Increase in prices of key inputs like refined vegetableoil and aspartame used in butter and sugarsubstitutes respectively has led to an increase in theraw material costs of the company
Fluctuations in foreign-exchange earnings
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
22/30
www.kredent.com research@kredent.com
22
Equity Research
ECONOMIC ACTIVITIES
The key product of the company includes:
Everyuth Menz Nutralite Sugarfree :
Sugarfree Gold Sugarfree Natura Sugarfree Dlite: Ready to drink and powder drink
Management Personnel:
Chairman: Mukesh M.Patel;
Also in the board of directors of Hitachi Home % Life Solutions,
Sandesh Ltd., FICCI, German Remedies Ltd.
Managing Director: Jitendra R. Patel
Board of directors:
Pankaj R. Patel H. Dhanrajgir Ganesh N. Nayek
Dr. Sharvil P. Patel
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
23/30
www.kredent.com research@kredent.com
23
Equity Research
Financial AnalysisAnnual:
Key Ratios 2006 2007 2008 2009
Sales (Rs. Cr) 30.91 42.7 56.33 194.74
Net Profit (Rs. Cr) 2.48 2.41 4.57 25.41
EBITDA Margin (%) 16.25 10.53 11.7 19.89
EBIT Margin (%) 13.87 9.54 10.42 19.04
Net Profit Margin (%) 7.86 5.5 7.89 12.98
ROCE 13.84 10.75 17.3 32.87
Sales Growth % (YoY) 8.43 38.18 32.09 244.06
EPS growth (YoY) -37.32 -38.05 89.63 -20.16
Retention Ratio 0.77 0.77 0.88 0.7
OCF Growth (%) 151.88 -24.32 -194.1 -1694.0
Debt-Equity 0 0 0 0
ROE 19.71 12.81 20.25 54.37
Current Ratio 10.6 5.96 2.4 2.05Source: Annual report
Analysis:
The companys pat margin has increased to 12.98% in FY 09 from 7.89 in FY08 mainly because ofgrowth in sales
EBIT & EBITDA Margins have increased over the last three years because the raw material costs and
the employee cost as % of sales have decreased substantially over the last three years which waspartially offset by an increase in the S&A expenses as % of sales over the same period Depreciation and amortization expenses doubled since majority of capital expenditure was capitalized
in Jan08, thus, depreciation on this additional capital was charged on full year in FY09 Higher sales growth was achieved due to higher sales of product in cosmetic segment like Everyuth Retention ratio has been almost constant while OCF growth is positive in FY09 standing at 45.75 cr.
from -2.87 cr. in FY08
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
24/30
www.kredent.com research@kredent.com
24
Equity Research
The company is a debt free company and its ROE has increased by more than double because of theincrease in its paid-up capital
Current Ratio has decreased in FY09 compared to FY06 because of huge increase in the currentliabilities of the company due to increase in provisions and advances from customers
Quarterly:
Key Rat ios 2 0 0 6 2 0 0 7 2 0 0 8 2 0 0 9
EBIT Margin (%) 17.05 24.02 10.09 17.8
Net Profit Margin (%) 11.51 15.64 7.83 13.12
Sales Growth (YoY) 579 -62.07 44.16 1.12
EPS growth (YoY) 26.28 -48.55 -28.09 70.31Source: BSE
Analysis:
The companies EBIT margin had increased in the last two quarters of FY08 but again fell in the first
quarter of FY09 because of high depreciation and amortization expenses
The Pat margins have also followed the same pattern of EBIT margin standing at 13.12% in thesecond quarter of FY09 higher than 7.83 of the first quarter of FY09 on account of low expenses
The sales growth of the company have been very fluctuating in the last few quarters which is a matterof concern
EPS growth has turned positive from the negative figures reported in the last quarters
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
25/30
www.kredent.com research@kredent.com
25
Equity Research
Kovai Medical Centre &Hospital Ltd.
BSE : 523323NSE : N.A.Bloomberg : KMC:INCMP : 102.75Sector : HealthcareView : Neutral
Key Metrics as on 11th January, 2010
Listing BSE
Current Price (Rs) 123.05
Market Cap (Rs Cr) 134.12
Free Float (%) 54.69
52-WEEK HIGH (Rs) 140
52-WEEK LOW (Rs) 43.00
BETA 0.41
P/B (x) 22.25
Current P/E (x) 6.04
PEG Ratio -
Dividend Yield (%) 0.01
Price Performance
Period Stock BSE
1 M 28.31 1.74
3 M 47.19 4.06
1 Year 115.5 86.33
Shareholders Pattern as on 30th Sep 2009
PROMOTER 45.31
FII -
DII 17.18
PUBLIC 19.76
OTHERS 17.75
Company Background:
Kovai Medical Centre & Hospital Ltd.is a 500 bed multi-disciplinary hospital with more than 50 medical disciplinesmanaged by highly qualified and skilled doctors andnurses. It is equipped with 11 operation theatres andtreats over 1000 patients everyday.
Investment Rationale:
The company is focused on increasing its top linegrowth and thus has strategically planned a Rs.200crore expansion plan around its present location inCoimbatore
It is recognized by the Royal College of Surgeons,Edinburgh to train AFRCS candidates. Under itsresearch & educational trust it offers graduate & postgraduate paramedical courses in various fields like inphysiotherapy, nursing pharmacy, physiotherapy,occupational therapy and nursing. It is also set toopen its own medical college in Coimbatore
It is recognized for organ transplant programmes bythe Govt. of Tamilnadu. It is one of the few centers inIndia to introduce new techniques in the treatment ofvarious specialized diseases.
The company has forayed into the treatment ofvarious lifestyle based diseases and is expected toreap profit in the light of the increasing trend in it. Ithas specialized clinics comprising of slim & diabeticcentre and also provides services related to cardiac,neuro and other fields
It has been consistently paying dividends to its
shareholders
Key Risks:
Mammoth investments required for expansion andmodernization programmes which may affect thefinancial health of the company in the initial years
The company is using a part of its internal funds forthe expansion of its campus
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
26/30
www.kredent.com research@kredent.com
26
Equity Research
ECONOMIC ACTIVITIES
The company provides all the facilities listed below:
Laboratory Services Pharmacy Blood Bank Artificial Limb Centre Immunization for Adults and Children Spech Therapy
Management Personnel:
Chairman & M.D: Dr. Nalla G Palaniswami
Vice Chairman & Joint Managing Director: Dr. Thavamani Devi Palaniswami
Board of Directors: Dr. Mohan S. Gounder Dr. Kasi K. Goundan
Dr. M. Manickam
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
27/30
www.kredent.com research@kredent.com
27
Equity Research
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
28/30
www.kredent.com research@kredent.com
28
Equity Research
Financial AnalysisAnnual:
Key Ratios 2006 2007 2008 2009
Sales (Rs. Cr) 51.17 64.66 87.54 110.36
Net Profit (Rs. Cr) 40.91 51.06 18.38 22.21
EBITDA Margin (%) 90.6 90.98 30.67 30.15
EBIT Margin (%) 84.6 85.54 26.27 26.6
Net Profit Margin (%) 79.22 78.29 20.67 19.91
ROCE 106.64 79.15 28.12 22.95
Sales Growth % (YoY) 26.19 26.36 35.39 26.07
EPS growth (YoY) 2260.6 24.81 -64 20.84
Debt-Equity 0.27 2.91 2.54 3.4
Interest Coverage 50.34 49.38 7.4 6.6
Current-Ratio 1.57 2.99 2.61 4.64Source: Annual Report
Analysis:
EBITDA Margins has decreased in the last two years because of higher operating expenses like S&A,raw-materials and employee cost
EBIT & PAT Margins have also decreased in the last two years because of falling EBITDA
Sales growth has almost been consistent standing at 110.36 cr except in FY08 when the growth was
35.39% Debt-Equity ratio has increased significantly from 1.57 in FY06 to 3.45 in FY09 because of increase in
the secured loans
Current-ratio has increased over the 4 years because of significant increase in cash and bankbalances
Interest-coverage has decreased over the years which is not a good sign for the company
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
29/30
www.kredent.com research@kredent.com
29
Equity Research
Quarterly:
Key Rat ios 2 0 06 20 0 7 2 0 08 20 0 9
EBIT Margin (%) 28.28 28.78 30.09 32.4
Net Profit Margin (%) 7.21 7.61 9.41 10.31
Sales Growth (YoY) 2.39 1.77 4.55 7.68
EPS growth (YoY) 73.15 7.49 28.36 18.22Source: BSE
Analysis:
THE EBIT Margin of the company has increased marginally in the last two years standing at 32.4 cr. inthe second quarter of FY09
Pat Margin has increased in the last two years standing at 10.31 cr in the first quarter of FY09compared to 9.41 cr in the second quarter of FY09
Sales has gradually started increasing in the last few quarters and the growth had touched 4.55% inthe first quarter of FY09 against 7.68% in the second quarter of FY09
EPS growth has been very fluctuative over the last 4 years standing at 18.22 in the second quarter ofFY09
http://www.kredent.com/mailto:research@kredent.commailto:research@kredent.comhttp://www.kredent.com/8/14/2019 Kredent_Indian Healthcare Sector
30/30
Equity Research
Kredent Brokerage Services Limited
Member: National Stock Exchange (Cash, FO & Currency)Bombay Stock Exchange Limited (Cash & FO)
Disclaimer: This document is for private circulation only. Neither the information nor any opinion expressedconstitutes an offer or any invitation to make an offer, to buy or sell any securities or any options, futures orother derivatives related to such securities (related investment). Kredent Brokerage Services Limited (KBSL)or any of its Associates or employees does not accept any liability whatsoever direct or indirect that may arisefrom the use of the information herein. KBSL and its may trade for their own accounts as market maker, blockpositioner, specialist and/or arbitrageur in any security of this Issuer(s) or in related investments, and may be onthe opposite side of public orders. KBSL, its affiliates, directors, officers, employees and employee benefit
programmes may have a long or short position in any securities of this Issuer(s) or in related investments. Nomatter contained herein may be reproduced without prior consent of KBSL. While this report has been preparedon the basis of published/other publicly available information considered reliable, we are unable to accept anyliability for the accuracy of its contents.
4, Brabourne Road ; 4th Floor ; Kolkata 700001Ph: +91 033 2225 3783/4/5/6/7
Fax :+91 033 2225 3788research@kredent.com
www.kredent.com
mailto:research@kredent.comhttp://www.kredent.com/http://www.kredent.com/mailto:research@kredent.com